Infinity Pharmaceuticals Inc.
|Market Cap (Intraday)||278.36M|
|2yr Forward PE||N/A|
Infinity Pharmaceuticals Inc. Stock, NASDAQ:INFI
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.